Indonesia represents a successful model of transition from an implementing country to an important contributor to global health, supported by a strong immunisation programme and resilient health system. Over the course of 22 years of partnership with Gavi, the country has doubled the number of vaccines offered through its routine immunisation programme, reduced child mortality four-fold and transitioned through all stages of Gavi support. 

With strong commitment to prevention-oriented health interventions, in December 2024, President Prabowo Subianto made a pledge of US$ 30 million to Gavi’s global immunisation efforts from 2026–2030, marking a historic contribution to Gavi core programme by a middle-income country that has transitioned from Gavi support. 

Proceeds to Gavi 6.0 as of 30 June 2026†
Contributions to Gavi Board approved financing instruments

*Local currency

†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.

Contributions and pledges per strategic period (US$ millions)

Hover over the bar chart above to view the data

Direct Contributions (including Matching Fund)

Non-US$ contributions are converted to US$ as follows:

  • Before Gavi 6.0 (2000–2025): exchange rate on date of receipt; where hedged (2014–2025), the hedge rate applies instead.
  • Gavi 6.0 (2026 onward, received & future contributions and Matching Fund Pledges): Bloomberg replenishment rate, 16:00 London time, 25 June 2025.

IFFIm Contributions

Non-US$ contributions are converted to US$ as follows:

  • Received Contributions: rate confirmed by the World Bank's International Bank for Reconstruction and Development (IBRD).
  • Future, signed contribution agreements: exchange rate at time of signing.
  • Future, unsigned contribution agreements: Bloomberg replenishment rate, 16:00 London time, 25 June 2025.

 

All donors